華昌達(300278.SZ):股東顏華所持839萬股司法拍賣股份流拍
格隆匯 9 月 28日丨華昌達(300278.SZ)公佈,公司於2020年9月2日披露了《關於公司持股5%以上股東所持公司股份將被司法拍賣的提示性公告》,股東顏華持有的4195萬股無限售流通股將分為5筆依次於2020年9月24日、9月29日、10月10日、10月15日、10月20日開始在京東司法拍賣網絡平台(http://sifa.jd.com)進行拍賣。
2020年9月28日,公司查詢了京東司法拍賣網絡平台,獲悉第一筆839萬股拍賣已流拍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.